<i>ITGA4</i> genetic variants as a predictor of therapeutic responsivity to autoimmune diseases. [PDF]
De Matos MD +5 more
europepmc +1 more source
Progress in Pharmacogenomics Implementation in the United States: Barrier Erosion and Remaining Challenges. [PDF]
Smith DM +18 more
europepmc +1 more source
Population Genetics of Pharmacogenetic Variants in a Greek Psychiatric Cohort of over 3000 Individuals. [PDF]
Ntoumou E +6 more
europepmc +1 more source
Self-Reported Pharmacogenetic Medication Use in the Our Future Health Cohort. [PDF]
Dixon P +4 more
europepmc +1 more source
Pharmacogenetic Analysis of TPMT and NUDT15 in a European Pediatric Cohort with IBD and Autoimmune Diseases: Frequency Data and Clinical Relevance. [PDF]
Pau A +10 more
europepmc +1 more source
Daily Cigarette Abstinence and Smoking Rate With Varenicline: Relationships With Treatment, Craving, and Affect During the First Week of the Quit Attempt. [PDF]
Tonkin SS +8 more
europepmc +1 more source
Life sciences and biotechnology – A strategy for Europe. Third progress report and future orientations. Report from the Commission to the European Parliament, the Council and the Economic and Social Committee. COM (2005) 286 final, 29 June 2005 [PDF]
core
Pharmacogenomic Calling From Whole-Exome Sequencing in the Taiwanese Population-A Real-World Experience. [PDF]
Lin HH +9 more
europepmc +1 more source

